Search Results 8091-8100 of 34364 for oral

1. Robotic surgery - Doctors & Departments - Mayo Clinic

   ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

2. Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas - Mayo Clinic

   Are able to swallow and retain oral tablets. Exclusion Criteria: Patients with any of the following sarcoma histologic subtypes will not be eligible for ...

3. A Study to Evaluate Firstline Pembrolizumab Alone or in Combination with Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients with Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   Patients with known EGFR mutations (except exon 20 insertion), BRAF mutations (V600) or ALK or ROS1 translocations that can be treated with oral tyrosine kinase ...

4. Publications - Chris Hartley, M.D. - Mayo Clinic

   Safety of endoscopic ultrasound-guided tissue acquisition with uninterrupted direct oral anticoagulation in a swine model. Endosc Int Open. 2023 Apr; 11(4): ...

5. Mayo Clinic Q and A: Cold cap therapy can reduce hair loss caused by chemotherapy

   DEAR MAYO CLINIC: How effective is cold cap therapy in preventing hair loss in people undergoing chemotherapy treatments? Are there any risks?

6. Cardiovascular Medicine - Clinical trials

   ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

7. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

   ... oral, inhaled or systemically injected steroids with duration >14 days, adrenocorticotropic hormone, verapamil). Past systemic immunosuppression medicine or ...

8. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

   inability to take oral medication;; malabsorption syndromes;; requirement for intravenous (IV) alimentation. Any active bleeding excluding hemorrhoidal or gum ...

9. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   Participants must be able to swallow and retain oral medications. Oxygen saturation > 92% on room air or up to 2 L/min supplemental oxygen by nasal cannula ...

10. Publications - Elizabeth H. Dineen, D.O. - Mayo Clinic

    2024. Kincaid CM, Sharma AN, Sargent B, Gradus-Pizlo I, Dineen EH, Mesinkovska NA. Evaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral ...